Regulatory tracker: AstraZeneca nabs key Imfinzi lung cancer approval in Europe

In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.

Mar 17, 2025 - 15:02
 0
Regulatory tracker: AstraZeneca nabs key Imfinzi lung cancer approval in Europe
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.